跳至主要内容
临床试验/NCT06313710
NCT06313710已完成不适用

Head Down Position for Successful Recanalization of Anterior Circulation Large Vessel Occlusion (HOPES3): a Prospective, Randomized, Open Label, Blinded-end Point, Single-center Study

General Hospital of Shenyang Military Region1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2024年8月30日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
90
试验地点
1
主要终点
Changes in National Institute of Health stroke scale (NIHSS)

研究概览

简要总结

This is a prospective, randomized, open label, blinded-end point, single-center study, aiming to investigate the effect of head down position in anterior circulation large vessel occlusion patients with successful recanalization after endovascular treatment.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Anterior circulation large vessel occlusion who received endovascular treatment within 24 hours of stroke onset;
  • •National Institute of Health Stroke Scale (NIHSS) ≥ 6 before endovascular treatment;
  • •Successful recanalization (mTICI 2b-3) after endovascular treatment;
  • •Cerebral circulation time based on DSA of the stroke side was slower than that of the healthy side after successful recanalization;
  • •ASPECTS ≥ 6 on CT or DWI;
  • •Absence of parenchymal hematoma on CT images done in the angio suite immediately after the procedure;
  • •Modified Rankin Scale score before stroke onset ≤ 1;
  • •Signed informed consent by patient or their legally authorized representative.

排除标准

  • •Hemorrhagic stroke: cerebral hemorrhage, subarachnoid hemorrhage;
  • •Severe hepatic or renal dysfunction, increase in ALT or AST (more than 2 times of upper limit of normal value), increase in serum creatinine (more than 1.5 times of upper limit of normal value) or requiring dialysis;
  • •After recanalization, severe and sustained (i.e., > 5 minutes) uncontrolled hypertension (systolic blood pressure over 180mmHg or diastolic blood pressure over 105 mmHg) refractory to antihypertensive medication;
  • •More than four retrieval attempts in the same vessel;
  • •Cardiac insufficiency (NYHA Class ≥II);
  • •Pregnancy, plan to get pregnant or during lactation;
  • •The estimated life expectancy is less than 6 months due to other serious diseases;
  • •Other conditions unsuitable for this clinical study assessed by researcher.

研究组 & 干预措施

control

No Intervention

low dose of head down position

Experimental

-10° Trendelenburg for 30 min

干预措施: head down position (Other)

high dose of head down position

Experimental

-10° Trendelenburg for 60 min

干预措施: head down position (Other)

结局指标

主要结局

Changes in National Institute of Health stroke scale (NIHSS)

时间窗: 24±8 hours

the minimum and maximum values of NIHSS are 0 and 42, respectively; higher NIHSS mean a worse outcome.

次要结局

  • ordinal distribution of modified Rankin Score (mRS)(90±7 days)
  • percentage of severe adverse events(24±8 hours)
  • changes in cerebral edema(24±8 hours)
  • Changes in National Institute of Health stroke scale (NIHSS)(10±2 days)
  • proportion of excellent functional outcome(90±7 days)
  • proportion of favorable functional outcome(90±7 days)
  • early neurological improvement (ENI)(24±8 hours)
  • changes in infarct volume(24±8 hours)
  • all-cause mortality(90±7 days)
  • proportion of intraparenchymal hemorrhage (PH)(24±8 hours)
  • new stroke or other vascular event(s)(90±7 days)
  • proportion of sympomatic intracranial hemorrhage(24±8 hours)

研究者

发起方
General Hospital of Shenyang Military Region
申办方类型
Other
责任方
Principal Investigator
主要研究者

Hui-Sheng Chen

Director

General Hospital of Shenyang Military Region

研究点 (1)

Loading locations...

相似试验